Zuguang W. Xia
No. 12 Wulumuqi Road
Shanghai, 200040, China
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Genomic landscape and molecular subtypes of primary central nervous system lymphoma.
Journal: Blood cancer journal
Published: August 06, 2025
Antibody-DNA nanostructure conjugates exhibit inhibited effects on CT26 cells and prevent upregulation of PD-1 in the tumor microenvironment.
Journal: International journal of biological macromolecules
Published: July 28, 2025
Corrigendum to "High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer" [Translational oncology vol. 50 (2024): 102128].
Journal: Translational oncology
Published: June 16, 2025
Antibody-DNA nanostructure conjugate enables targeted delivery of gemcitabine to tumor and improves the anti-tumor efficacy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 05, 2024
Lenalidomide combined with R-CHOP (R2-CHOP) in the treatment of newly diagnosed double-expressor diffuse large B-cell lymphoma: a prospective phase II clinical trial.
Journal: Blood cancer journal
Published: October 04, 2024
PD-1 inhibitors plus chemotherapy for refractory EBV-positive DLBCL: a retrospective analysis.
Journal: Blood research
Published: August 16, 2024
Prognostic Significance of Deubiquitinase OTUD7B in NK/T-Cell Lymphoma.
Journal: Asia-Pacific journal of clinical oncology
Published: July 22, 2024
High expression of PAX8-AS1 correlates with poor prognosis and response to fluorouracil-based chemotherapy in stage II colon cancer.
Journal: Translational oncology
Published: June 12, 2024
Histone-acetyl epigenome regulates TGF-β pathway-associated chemoresistance in colorectal cancer.
Journal: Translational oncology
Published: May 08, 2024
Last Updated: 09/26/2026